Trials / Unknown
UnknownNCT04610983
Omega-3 Bioavailability From Vegetable-omega-3 Enriched Products
Bioavailability of Omega-3 Long-chain Polyunsaturated Fatty Acids (LCPUFA) From Foods Enriched With Vegetable-encapsulated Omega-3 Oils
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Commonwealth Scientific and Industrial Research Organisation, Australia · Other Government
- Sex
- Male
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
CSIRO's Food Program has developed a novel vegetable-based Omega-3 long-chain polyunsaturated fatty acid (Omega 3)encapsulant to be used as ingredient in various food products, however, it is unknown whether the vegetable-based carrier matrix will affect omega-3 bioavailability. This project aims to compare the bioavailability of omega-3 from two test foods containing vegetable (cauliflower)-encapsulated algal oil (the "ingredient") against a control test product (algal oil gel capsules) across two ethnicities (Australian European vs. Chinese Singaporean).
Detailed description
Omega-3 long-chain polyunsaturated fatty acids (omega-3) (eicosapentaenoic acid \[EPA\] and docosahexaenoic acid \[DHA\]) is associated with many health benefits including improved brain, heart, joint and eye health. However, \<20% of the world's population consume adequate amounts of these fatty acids. Individuals who don't consume fish (major dietary omega-3 source) and particularly vegans/vegetarians are at greatest risk of omega-3 deficiency. Convenient strategies empowering consumers to increase their omega-3 intake have potential to significantly impact health outcomes. CSIRO's Food Program has developed a novel vegetable-based omega-3 encapsulant to be used as ingredient in various food products. Using algal oil as omega-3 source provides vegan/vegetarian options. However, it is unknown whether the vegetable-based carrier matrix will affect omega-3 bioavailability. As these products are intended for global markets, it is also unknown whether ethnic differences may affect omega-3 bioavailability. This project forms part of a larger project aiming to develop sensorially and culturally acceptable food products that incorporate vegetable-encapsulated omega-3 oils to assist Australian and Singaporean consumers to achieve their omega-3 LCPUFA intake. This component of the project aims to compare the bioavailability of omega-3 from two test foods containing vegetable (cauliflower)-encapsulated algal oil (the "ingredient") against a control test product (algal oil gel capsules) across two ethnicities (Australian European vs. Chinese Singaporean). To achieve this, two clinical trials, following the same protocol, will be executed in both Australia (Australian European) and Singapore (Chinese Singaporean).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Experimental: Control | 2 x algal oil gel capsules delivering 400mg DHA in total |
| DIETARY_SUPPLEMENT | Experimental: Treatment 1 - Semi-Solid food matrix | Test Food 1: 200g serve soup + "ingredient" |
| DIETARY_SUPPLEMENT | Treatment 2 - Solid food matrix | Test Food 2: 50g serve extruded snack (savoury snack) + "ingredient" |
Timeline
- Start date
- 2020-11-16
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
- First posted
- 2020-11-02
- Last updated
- 2020-11-02
Locations
2 sites across 2 countries: Australia, Singapore
Source: ClinicalTrials.gov record NCT04610983. Inclusion in this directory is not an endorsement.